Welcome to Dr. Elliott Antman's AHA Emerging Science™ Series.

AHA is proud to introduce a new program to further science collaboration hosted by Dr. Elliot Antman: The AHA Emerging Science™ Series webinars are one hour professional quality webinars held three times per year. Dr. Antman will host each webinar, which will have two 30 minute blocks, consisting of presentations of original research from the following categories:

  • Late Breaking Clinical Trials
  • Clinical Trial Updates of previously presented LBCTs
  • Late Breaking Basic Science
  • Major Bench-to-Bedside Advances
  • Major Conference Proceedings
  • Major Guidelines/Policy Statements

The live webinar events will be viewable from a computer or mobile phone, both live and on-demand. Attendees can ask questions electronically during the live event or post event. View the ESS Brochure here

Join us at the next event, or view this blog for past events.

Latest Posts

Archive for April, 2012

AHA's Emerging Science™ Series is accepting submissions until May 9, 2012, 5 p.m. CDT (UTC -05).

http://scientificsessions.org/emergingscience


For learning objectives and submission guidelines, please click these links:
ESS Learning Objectives & ESS Science Submission Guidelines

more...
Posted by Alyson PON Editor on Apr 27, 2012 9:54 AM CDT
ESS Banner

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, 12:00 noon - 1:05 pm

Moderators: 
  • Elliott Antman
  • Robert Harrington
  • Robert Bonow
Panelists:
  • John Murkin
  • Jeffrey Weitz 
  • Mark Clay               

more...
Posted by Alyson PON Editor on Apr 27, 2012 9:44 AM CDT
ESS Banner

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, 12:00 noon - 1:05 pm

Button_RegisterNow_Small

Presentation Topics: 


  1. Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  
    Presenter: Jonathan P. Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC
    View abstract   |   Science News Summary 
     
  2. Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery  
    Presenter: Ronald B. Easley, Baylor Coll of Med, Houston, TX
    View manuscript   |   Science News Summary
more...
Posted by Alyson PON Editor on Apr 24, 2012 9:32 AM CDT

Most Recent Comments

I am intrigued by this exciting new AHA Emerging Science Series, and particularly interested to hear the discussio...
I am very enthusiastic to hear more about tissue engineered vascular grafts. The science is quite provocative and t...
As the Director of the Adult Invasive and Interventional Cardiology Program in Nassau, The Bahamas, I am excited to...
I am pleased to see a translational science presentation in this first webinar of the AHA Emerging Science Series. U...
The PLATO US substudy raises a number of important questions that will attract the attention of clinical trialists...